On August 31, 2022 the FDA announced the emergency use authorisation of the new COVID-19 bivalent booster vaccine formulations both Moderna and Pfizer-BioNTech with NO human trials and NO advisory panel consultation, hopefully it will work! The formulation contains the mRNA spike protein code for the extinct original Wuhan strain plus “one in common between [!!!] the BA.4 and BA.5 lineages of the omicron variant of SARS-CoV-2″. They will be referred to as “updated boosters” [1, 2]
“The company has tested the BA.5-specific vaccine only on [eight] mice, so far, and is relying on data from both the BA.1 human trials and the BA.5 mice trials for their submission for authorisation”. A vaccine expert John Moore says “to rely only on mouse data (for authorisation) would be unprecedented“! But both of these vaccines do not contain the mRNA code use in this new EUA.
FDA Commissioner Robert Califf tweeted, “As we know from prior experience, strain changes can be made without affecting safety.” He is considering this new technology vaccine the same as an influenza “strain change“, but is ignoring the trail of destruction.
The following day on September 1, 2022, CDC’s ACIP committee recommend the use of the new bivalent jab for 12 years and older for Pfizer, and 18 years for Moderna. [1, 2]
The Moderna BA.1 vaccine was authorised in the UK on August 15, 2022.
The World Council for Health continues to call for a HALT on these injectable products.